TerrAscend Corp. TRSSF TER announced on June 23 that it closed the first tranche of its previously announced concurrent private placements for total gross proceeds of approximately $16 million, upsizing the offering to $20 million. A second tranche closing is scheduled for June 28, 2023.
The closing of the initial tranche of the private placements consists of an aggregate of 4,071,577 units of the company at a price of $1.50 per unit for aggregate gross proceeds of approximately $6.1 million and 9,905 senior unsecured convertible debentures of the company at a price of $1,000 per debenture for aggregate gross proceeds of $9.9 million. Proceeds will be used for TSX listing qualification, Maryland dispensary acquisitions, and general corporate purposes.
See also: TerrAscend To Acquire 8,500 Square Foot Cannabis Dispensary In Maryland For $22.1M
Equity Offering
The Equity Offering consists of units containing one common share and one-half of a warrant. Each warrant allows the holder to purchase a common share at $1.95 within 24 months after the Equity Offering closes.
Debenture Offering
The debentures will be due for repayment in 36 months unless repaid or converted earlier. They accrue 9.9% interest annually, payable on the debenture offering (the “maturity date”). Holders can choose to receive up to 4.95% of the interest in cash semi-annually. Debentures can be converted into Common Shares at any time before the maturity date at a conversion price of $2.01, with accrued interest included.
Company insiders took part in the private placement, purchasing 2,000 debentures and 25,732 Units. Additionally, 300,000 Warrants were issued under the same terms. A cash commission, ranging from 1% to 3.75% of the gross proceeds, will be paid based on the funding source.
Price action: On Monday, before the market closed, TRSSF shares were trading up 0.23% at $1.65 per share.
Read More: TerrAscend's $22M Purchase Of Peninsula Alternative Health Approved By Maryland's Cannabis Admin
Image by Pixabay // Edited by Benzinga
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.